Jeil Pharma Holdings, 13.74% ↑ Amid COVID-19 (Nafamostat) Theme Uptrend

On the 19th, the COVID-19 (Nafamostat) theme showed strength by rising 3.99% compared to the previous day, while Jeil Pharma Holdings, a related stock drawing attention, surged 13.74% compared to the previous day. Jeil Pharma Holdings is known to have converted into a holding company in June 2017.

[Graph] Major stock price changes in the COVID-19 (Nafamostat) theme

According to the analysis by Thinkpool Robo Algorithm RASSI, Jeil Pharma Holdings’ quant financial score is 24.84 points, which is higher in growth and stability scores than the average of other stocks related to COVID-19 (Nafamostat), ranking 6th within the theme. This indicates that compared to other stocks in the theme, Jeil Pharma Holdings shows a relatively fast increase in sales and net profit, as well as good responsiveness to changes in domestic and international economic environments.

[Table] Top stocks by financial score within the theme

※ The quant financial score is the result of the Robo Algorithm’s analysis based on each company’s sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, and other factors.

※ This article was generated in real time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.